Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers
VIS649 (Sibeprenlimab)(一种 APRIL 中和 IgG2 单克隆抗体)在健康志愿者中的安全性、耐受性、药代动力学和药效学
期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2022.01.1073
Mohit Mathur, Jonathan Barratt, Yusuke Suzuki, Frank Engler, Marcela F Pasetti, Jill Yarbrough, Susan Sloan, David Oldach